Loading...

Cognetivity Neurosciences Ltd.

CGNSF•PNK
HealthcareMedical - Healthcare Information Services
$0.00
$0.00(0.00%)

Cognetivity Neurosciences Ltd. (CGNSF) Stock Overview

Explore Cognetivity Neurosciences Ltd.’s financial performance, market position, analyst ratings, and future outlook.

Stats data is not available for CGNSFStats details for CGNSF are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.
Analyst Recommendations data is not available for CGNSFAnalyst Recommendations details for CGNSF are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Company Profile

Cognetivity Neurosciences Ltd. operates as a healthcare company. It develops an integrated cognitive assessment, a cognitive testing platform for use in medical, commercial, and consumer environments that helps to detect the earliest signs of impairment by testing the performance of large areas of the brain to support the diagnosis of dementia; and offers OptiMind, a wellness app. The company was formerly known as Utor Capital Corp. and changed its name to Cognetivity Neurosciences Ltd. in December 2017. Cognetivity Neurosciences Ltd. was incorporated in 2015 and is headquartered in Vancouver, Canada.

CEO

Dr. Sina Habibi

Employees

2,500

Headquarters

1055 West Hastings Street, Vancouver, BC

Founded

2021

Frequently Asked Questions